Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination
Share

Tippi MacKenzie: In Utero Hematopoietic Cell Transplantation for Hematologic Conditions

December 30, 2021
Content License:Private

In utero hematopoietic cell transplantation showed promise in a phase 1 clinical trial involving fetuses with alpha thalassemia major. Here, Tippi Mackenzie, MD, discusses interim results from the study.

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
October 2024

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals